Meningeal Carcinomatosis: all 146 studies
Page 2 of 2. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.
- BATs in Patients With Breast Cancer and Leptomeningeal MetastasesTerminatedNCT03661424Phase 1
- ANG1005 in Leptomeningeal Disease From Breast CancerStatus unknownNCT03613181Phase 3
- Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal MetastasesCompletedNCT03520504Phase 1
- Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid TumorsCompletedNCT03507244Phase 1/2
- Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung CancerCompletedNCT03101579Phase 1
- Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid TumorsCompletedNCT03082144Phase 2
- Tomotherapy for Refractory Brain MetastasesStatus unknownNCT03027544Not applicable
- A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal MetastasisStatus unknownNCT02803619
- Expanded Access to ANG1005 for Individual PatientsNo longer availableNCT02755987
- Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain TumorsTerminatedNCT02684071Phase 2
- Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain MetastasesCompletedNCT02654106Phase 2
- A Prospective, Observational Trial on the Diagnostic and Prognostic of LMStatus unknownNCT02607605
- Different Dose of Methotrexate for the Treatment of Meningeal CarcinomatosisStatus unknownNCT02590510Phase 4
- Safety Study of Afatinib for Brain CancerCompletedNCT02423525Phase 1
- Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung CancerCompletedNCT02228369Phase 1
- Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)CompletedNCT02071056
- Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal MetastasesStatus unknownNCT01818713Phase 2
- Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal MetastasesCompletedNCT01713699Not applicable
- Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast CancerCompletedNCT01645839Phase 3
- Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal DiseaseWithdrawnNCT01438021Not applicable
- Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous MeningitisCompletedNCT01373710Phase 1/2
- Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal MetastasisCompletedNCT01281696Phase 2
- Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal SyndromeStatus unknownNCT00938756Not applicable
- Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.CompletedNCT00854867Phase 1
- A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung CancerTerminatedNCT00830245Phase 2
- Phase 1 Intrathecal Topotecan for Neoplastic MeningitisCompletedNCT00674674Phase 1
- A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic MeningitisTerminatedNCT00527410Phase 1
- DepoCyt Plus Temozolomide in Patients With Neoplastic MeningitisTerminatedNCT00515788Phase 1
- RTA 744 Injection in Patients With Leptomeningeal DiseaseTerminatedNCT00512460Phase 1
- Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPATerminatedNCT00477503Phase 1
- Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesCompletedNCT00424242Early Phase 1
- Intrathecal Rituximab in Treating Patients With Recurrent CNS LymphomaCompletedNCT00416923Phase 1
- Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid TumorsTerminatedNCT00112619Phase 1
- Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerTerminatedNCT00089245Phase 1
- Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT GemcitabineTerminatedNCT00074607Phase 1
- Mafosfamide in Treating Patients With Progressive or Refractory Meningeal TumorsCompletedNCT00031928Phase 1
- Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the BrainCompletedNCT00025311Phase 1
- Busulfan in Treating Children and Adolescents With Refractory CNS CancerCompletedNCT00006246Phase 1
- Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerCompletedNCT00005842Phase 1
- Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or LymphomaTerminatedNCT00005812Phase 2
- Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous TreatmentCompletedNCT00005811Phase 2
- Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal TumorsCompletedNCT00003462Phase 1
- Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid TumorsStatus unknownNCT00003073Phase 1
- LMB-7 Immunotoxin in Treating Patients With Leptomeningeal MetastasesCompletedNCT00003020Phase 1
- Monoclonal Antibody Therapy in Treating Patients With Brain MetastasesCompletedNCT00002751Phase 1/2
- Melphalan in Patients With Neoplastic MeningitisCompletedNCT00002750Phase 1